Home › Funds › Spyglass Capital Management LLC › MEDP

Spyglass Capital Management LLC position in MEDP

MEDPACE HLDGS INC · Health Care

Spyglass Capital Management LLC reported holding 68,433 shares of MEDP (MEDPACE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$42.7M, representing 2.49% of its reported portfolio and ranking #22 among its reported holdings. Spyglass Capital Management LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)68.43K sh
Reported value held$42.71M
Portfolio Weight2.49%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Spyglass Capital Management LLC's MEDP position evolved

Spyglass Capital Management LLC first disclosed a stake in MEDP in Q3 2023 at 159,273 shares (US$38.6M). The position peaked in Q4 2024 at 262,660 shares, worth US$87.3M. Across 13 filings, Spyglass Capital Management LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 68,433 shares valued at US$42.7M — a reduction of -51,932 shares quarter over quarter.. Notable position changes include a 85% increase in Q4 2024 (shares fell 8% over the following quarter), a 54% trim in Q4 2025 (shares fell 15% over the following quarter), a 116% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 159.27K $38.56M New
Q4 2023 151.73K $46.51M Reduce
Q1 2024 110.81K $44.78M Reduce
Q2 2024 109.42K $45.06M Reduce
Q3 2024 141.88K $47.36M Add
Q4 2024 262.66K $87.26M Add
Q1 2025 242.15K $73.78M Reduce
Q2 2025 224.47K $70.45M Reduce
Q3 2025 150.88K $77.58M Reduce
Q4 2025 69.17K $38.85M Reduce
Q1 2026 55.76K $26.77M Reduce
Q2 2026 120.36K $63.74M Add
Q3 2026 68.43K $42.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MEDP and 13F data

MEDP (MEDPACE HLDGS INC) is a Health Care company. 43 other funds we track also report a position in MEDP — the largest reported positions include WASATCH ADVISORS LP (US$290.8M), Renaissance Technologies (US$282.4M), Giverny Capital Inc. (US$152.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MEDP

All MEDP fund holders →

FAQ

How long has Spyglass Capital Management LLC held MEDP?

Spyglass Capital Management LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Spyglass Capital Management LLC's current position in MEDP?

As of Q3 2026, Spyglass Capital Management LLC holds 68.43K shares of MEDP (MEDPACE HLDGS INC), valued at $42.71M, representing 2.49% of its reported portfolio and ranking #22.

Has Spyglass Capital Management LLC been buying or selling MEDP?

In the latest 13F filing (Q3 2026), Spyglass Capital Management LLC reduced its position in MEDP. The position peaked in Q4 2024 at 262.66K shares.

Which other funds hold MEDP?

Other major institutional holders of MEDP include WASATCH ADVISORS LP, Renaissance Technologies, Giverny Capital Inc., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.